Follow Us On:
Follow Us On:
Our globally integrated bioanalytical solutions ensure cost efficiency, accelerated clinical programs, and precise results across all phases of drug development.
CurexBio offers a full suite of integrated bioanalytical support services, meticulously designed to meet the diverse and evolving needs of modern drug development programs. Our expertise aligns seamlessly with Pre-Clinical Support and Central Lab Support to ensure scientific rigor and regulatory compliance across all study stages.
The foundation of reliable bioanalytical data lies in robust analytical methods. We specialize in method development and validation, crafting highly specific, sensitive, and reproducible assays for the quantification of small molecules, biologics, and biomarkers in various biological matrices (e.g., plasma, serum, urine, tissue). Our validation processes strictly adhere to global regulatory guidelines (e.g., FDA, EMA GLP/GCP), ensuring the method’s fitness for purpose in terms of linearity, accuracy, precision, selectivity, recovery, and stability. This rigorous approach minimizes variability and maximizes data integrity.
Our expert team conducts precise sample analysis utilizing cutting-edge technologies, primarily focusing on advanced LC-MS/MS (Liquid Chromatography-Mass Spectrometry/Mass Spectrometry) platforms. This powerful technique offers unparalleled sensitivity, selectivity, and speed, crucial for quantifying analytes at very low concentrations in complex biological samples. We ensure:
The bioanalytical support data we generate is fundamental for comprehensive Pharmacokinetic (PK) and Pharmacodynamic (PD) support. By precisely quantifying drug concentrations over time, we help characterize a drug’s ADME profile, enabling sponsors to:
Biomarkers are increasingly pivotal in drug development, offering insights into disease progression, therapeutic response, and potential toxicity. CurexBio provides comprehensive biomarker analysis, developing and validating assays for novel and established biomarkers. This support aids in patient stratification, early efficacy detection, and personalized medicine approaches, accelerating decision-making throughout the development process.
For the development of biologics, assessing potential immunogenicity (the body’s immune response to a therapeutic protein) is critical. We offer specialized immunogenicity testing services, including screening, confirmation, and characterization assays for anti-drug antibodies (ADA), as well as neutralizing antibody (NAb) assays. This helps in comprehending the long-term safety and efficacy of biologic drugs.
Effective project management is key to seamless bioanalytical operations. Our experienced Bioanalytical Project Management team provides strategic oversight from study conception to final report. They coordinate between study teams, analytical labs, and regulatory affairs, ensuring project timelines and quality standards are met, and promptly addressing any technical or quality issues, providing a single point of contact for streamlined communication.
We offer an array of niche and full-fledged CRO services, from clinical trial protocol development to post-marketing surveillance. Streamline Your Drug Development with Curexbio CRO Expertise
Bioanalytical testing ensures accurate measurement of drug concentration and biological responses, helping researchers understand how a drug behaves in the body. This data is essential for determining safe dosage, monitoring efficacy, and meeting regulatory requirements.
Bioanalytical support services include method development and validation, sample analysis using advanced techniques like LC-MS/MS, pharmacokinetic (PK) and pharmacodynamic (PD) studies, biomarker analysis, and immunogenicity testing for biologics
CurexBio is a trusted CRO offering integrated bioanalytical support with advanced technologies like LC-MS/MS, ensuring high accuracy and sensitivity in sample analysis. Our expert team follows global regulatory standards such as FDA and GCP guidelines, delivering reliable, compliant, and high-quality data across all phases of drug development.
CurexBio provides comprehensive bioanalytical solutions including method development, validation, sample analysis, PK/PD studies, biomarker analysis, and immunogenicity testing. Our integrated approach ensures seamless coordination with clinical and preclinical workflows, helping sponsors accelerate timelines while maintaining data integrity and regulatory compliance.
CurexBio ensures quality and regulatory compliance by following strict global guidelines such as FDA, GLP, and ICH standards. Our bioanalytical processes include validated methods, robust quality control systems, and detailed documentation to maintain data accuracy, reproducibility, and audit readiness throughout the study lifecycle.
1113, Silver Radiance 4 Sarkhej – Gandhinagar Hwy, Chanakyapuri, Ahmedabad, Gujarat 382481
7851 SW Ellipse Way Suite 16 Stuart, Florida 34997
203 Ziadodda Cresent, Brampton,Ontario, L6P1T4
© Copyright 2025 Curexbio. All Rights Reserved
